[BPMC] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[BPMC] Blueprint Medicines Corporation
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 5.42%
YoY- -29.64%
Quarter Report
BPMC's Result
BPMC's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 65,977 24,188 745,118 9,139 1,095 8,068 6,160 48.44%
PBT -132,277 -117,066 634,348 -94,275 -72,723 -37,703 -16,834 40.97%
Tax 886 175 370 3,698 2,813 1,001 267 22.11%
NP -133,163 -117,241 633,978 -94,275 -72,723 -37,703 -16,834 41.13%
Tax Rate - - -0.06% - - - - -
Total Cost 199,140 141,429 111,140 103,414 73,818 45,771 22,994 43.28%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -201.83 -484.71 85.08 -1,031.57 -6,641.37 -467.32 -273.28 -4.92%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -2.23 -2.00 11.49 -1.93 -1.66 -0.96 -0.62 23.76%
EPS Diluted -2.23 -2.00 11.16 -1.93 -1.66 -0.96 -0.62 23.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.